• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995 年至 2010 年间诊断的爱尔兰肌萎缩侧索硬化症患者的生存分析。

Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.

机构信息

Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Dublin, Ireland.

出版信息

PLoS One. 2013 Sep 30;8(9):e74733. doi: 10.1371/journal.pone.0074733. eCollection 2013.

DOI:10.1371/journal.pone.0074733
PMID:24098664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3786977/
Abstract

INTRODUCTION

The Irish ALS register is a valuable resource for examining survival factors in Irish ALS patients. Cox regression has become the default tool for survival analysis, but recently new classes of flexible parametric survival analysis tools known as Royston-Parmar models have become available.

METHODS

We employed Cox proportional hazards and Royston-Parmar flexible parametric modeling to examine factors affecting survival in Irish ALS patients. We further examined the effect of choice of timescale on Cox models and the proportional hazards assumption, and extended both Cox and Royston-Parmar models with time varying components.

RESULTS

On comparison of models we chose a Royston-Parmar proportional hazards model without time varying covariates as the best fit. Using this model we confirmed the association of known survival markers in ALS including age at diagnosis (Hazard Ratio (HR) 1.34 per 10 year increase; 95% CI 1.26-1.42), diagnostic delay (HR 0.96 per 12 weeks delay; 95% CI 0.94-0.97), Definite ALS (HR 1.47 95% CI 1.17-1.84), bulbar onset disease (HR 1.58 95% CI 1.33-1.87), riluzole use (HR 0.72 95% CI 0.61-0.85) and attendance at an ALS clinic (HR 0.74 95% CI 0.64-0.86).

DISCUSSION

Our analysis explored the strengths and weaknesses of Cox proportional hazard and Royston-Parmar flexible parametric methods. By including time varying components we were able to gain deeper understanding of the dataset. Variation in survival between time periods appears to be due to missing data in the first time period. The use of age as timescale to account for confounding by age resolved breaches of the proportional hazards assumption, but in doing so may have obscured deficiencies in the data. Our study demonstrates the need to test for, and fully explore, breaches of the Cox proportional hazards assumption. Royston-Parmar flexible parametric modeling proved a powerful method for achieving this.

摘要

简介

爱尔兰 ALS 注册是研究爱尔兰 ALS 患者生存因素的宝贵资源。Cox 回归已成为生存分析的默认工具,但最近出现了新的灵活参数生存分析工具类别,称为 Royston-Parmar 模型。

方法

我们使用 Cox 比例风险和 Royston-Parmar 灵活参数建模来检查影响爱尔兰 ALS 患者生存的因素。我们进一步检查了 Cox 模型和比例风险假设中时间尺度选择的影响,并使用时间变化成分扩展了 Cox 和 Royston-Parmar 模型。

结果

在模型比较中,我们选择了一个没有时间变化协变量的 Royston-Parmar 比例风险模型作为最佳拟合。使用该模型,我们确认了与 ALS 中已知生存标志物的关联,包括诊断时的年龄(每增加 10 岁的风险比(HR)为 1.34;95%CI 为 1.26-1.42)、诊断延迟(每延迟 12 周的 HR 为 0.96;95%CI 为 0.94-0.97)、明确的 ALS(HR 为 1.47;95%CI 为 1.17-1.84)、延髓发病疾病(HR 为 1.58;95%CI 为 1.33-1.87)、利鲁唑使用(HR 为 0.72;95%CI 为 0.61-0.85)和参加 ALS 诊所(HR 为 0.74;95%CI 为 0.64-0.86)。

讨论

我们的分析探讨了 Cox 比例风险和 Royston-Parmar 灵活参数方法的优缺点。通过包含时间变化成分,我们能够更深入地了解数据集。时间段之间的生存差异似乎是由于第一个时间段中的缺失数据造成的。使用年龄作为时间尺度来解释年龄混杂的比例风险假设的违反,但这样做可能掩盖了数据的缺陷。我们的研究表明,需要测试并充分探索 Cox 比例风险假设的违反情况。Royston-Parmar 灵活参数建模被证明是实现这一目标的强大方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/b1d09f2fe29b/pone.0074733.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/b52eb49ec757/pone.0074733.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/e1cad6c2bfa7/pone.0074733.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/09b5229e4d1e/pone.0074733.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/b1d09f2fe29b/pone.0074733.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/b52eb49ec757/pone.0074733.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/e1cad6c2bfa7/pone.0074733.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/09b5229e4d1e/pone.0074733.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f25/3786977/b1d09f2fe29b/pone.0074733.g004.jpg

相似文献

1
Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.1995 年至 2010 年间诊断的爱尔兰肌萎缩侧索硬化症患者的生存分析。
PLoS One. 2013 Sep 30;8(9):e74733. doi: 10.1371/journal.pone.0074733. eCollection 2013.
2
Survival analysis of geospatial factors in the Irish ALS cohort.爱尔兰肌萎缩侧索硬化症队列中地理空间因素的生存分析。
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct-Nov;17(7-8):555-560. doi: 10.1080/21678421.2016.1179326. Epub 2016 May 4.
3
Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021.爱尔兰肌萎缩侧索硬化症的流行病学趋势,1996-2021 年。
Neurology. 2023 Nov 7;101(19):e1905-e1912. doi: 10.1212/WNL.0000000000207797. Epub 2023 Sep 25.
4
A flexible alternative to the Cox proportional hazards model for assessing the prognostic accuracy of hospice patient survival.用于评估临终关怀患者生存预后准确性的 Cox 比例风险模型的一种灵活替代方法。
PLoS One. 2012;7(10):e47804. doi: 10.1371/journal.pone.0047804. Epub 2012 Oct 17.
5
The current application of the Royston-Parmar model for prognostic modeling in health research: a scoping review.Royston-Parmar模型在健康研究预后建模中的当前应用:一项范围综述
Diagn Progn Res. 2018 Feb 7;2:4. doi: 10.1186/s41512-018-0026-5. eCollection 2018.
6
Early onset but long survival and other prognostic factors in Chinese sporadic amyotrophic lateral sclerosis.中国散发性肌萎缩侧索硬化症的早期发病但长期生存和其他预后因素。
J Clin Neurosci. 2019 Nov;69:74-80. doi: 10.1016/j.jocn.2019.08.030. Epub 2019 Aug 22.
7
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.肌萎缩侧索硬化症患者的预后:个体化预测模型的建立和验证。
Lancet Neurol. 2018 May;17(5):423-433. doi: 10.1016/S1474-4422(18)30089-9. Epub 2018 Mar 26.
8
Royston-Parmar flexible parametric survival model to predict the probability of keratoconus progression to corneal transplantation.Royston-Parmar 灵活参数生存模型预测圆锥角膜进展为角膜移植的概率。
Eye (Lond). 2020 Apr;34(4):657-662. doi: 10.1038/s41433-019-0554-4. Epub 2019 Aug 28.
9
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).利鲁唑用于治疗肌萎缩侧索硬化症(ALS)/运动神经元病(MND)。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206.
10
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?当代肌萎缩侧索硬化症患者疾病进展较慢且生存期延长:肌萎缩侧索硬化症的自然史正在改变吗?
Arch Neurol. 2006 Aug;63(8):1139-43. doi: 10.1001/archneur.63.8.1139.

引用本文的文献

1
Long-stay ICU patients with frailty: mortality and recovery outcomes at 6 months.长期入住重症监护病房的虚弱患者:6个月时的死亡率和康复结果
Ann Intensive Care. 2024 Feb 24;14(1):31. doi: 10.1186/s13613-024-01261-x.
2
Functional network dynamics revealed by EEG microstates reflect cognitive decline in amyotrophic lateral sclerosis.脑电图微观状态揭示的功能网络动态反映了肌萎缩侧索硬化症的认知能力下降。
Hum Brain Mapp. 2024 Jan;45(1):e26536. doi: 10.1002/hbm.26536. Epub 2023 Dec 13.
3
Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021.

本文引用的文献

1
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).利鲁唑用于治疗肌萎缩侧索硬化症(ALS)/运动神经元病(MND)。
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD001447. doi: 10.1002/14651858.CD001447.pub3.
2
Clinical diagnosis and management of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的临床诊断与管理。
Nat Rev Neurol. 2011 Oct 11;7(11):639-49. doi: 10.1038/nrneurol.2011.153.
3
Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.执行功能障碍是无痴呆 ALS 患者的负面预后指标。
爱尔兰肌萎缩侧索硬化症的流行病学趋势,1996-2021 年。
Neurology. 2023 Nov 7;101(19):e1905-e1912. doi: 10.1212/WNL.0000000000207797. Epub 2023 Sep 25.
4
Care, burden and self-described positive aspects of caring in amyotrophic lateral sclerosis: an exploratory, longitudinal, mixed-methods study.肌萎缩侧索硬化症患者的护理、负担和自我描述的积极方面:一项探索性、纵向、混合方法研究。
BMJ Open. 2023 Jan 20;13(1):e064254. doi: 10.1136/bmjopen-2022-064254.
5
Rate of speech decline in individuals with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者言语下降率。
Sci Rep. 2022 Sep 20;12(1):15713. doi: 10.1038/s41598-022-19651-1.
6
Patterns of Language Impairment in Early Amyotrophic Lateral Sclerosis.早期肌萎缩侧索硬化症的语言障碍模式
Neurol Clin Pract. 2021 Oct;11(5):e634-e644. doi: 10.1212/CPJ.0000000000001006.
7
Informal Caregivers in Amyotrophic Lateral Sclerosis: A Multi-Centre, Exploratory Study of Burden and Difficulties.肌萎缩侧索硬化症的非正式照料者:一项关于负担与困难的多中心探索性研究
Brain Sci. 2021 Aug 20;11(8):1094. doi: 10.3390/brainsci11081094.
8
Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis.肌萎缩侧索硬化症的多学科护理:一项系统评价和荟萃分析。
Neurol Sci. 2021 Mar;42(3):911-923. doi: 10.1007/s10072-020-05011-2. Epub 2021 Jan 14.
9
Individual quality of life in spousal ALS patient-caregiver dyads.配偶 ALS 患者-照顾者对个体生活质量的影响。
Health Qual Life Outcomes. 2020 Nov 23;18(1):371. doi: 10.1186/s12955-020-01551-5.
10
[Not Available].[无可用内容]。
CMAJ. 2020 Nov 16;192(46):E1505-E1521. doi: 10.1503/cmaj.191721-f.
Neurology. 2011 Apr 5;76(14):1263-9. doi: 10.1212/WNL.0b013e318214359f.
4
Prognostic factors in ALS: A critical review.肌萎缩侧索硬化症的预后因素:一项批判性综述。
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):310-23. doi: 10.3109/17482960802566824.
5
Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.肌萎缩侧索硬化症长期生存的预测因素:一项基于人群的研究。
J Neurol Sci. 2008 May 15;268(1-2):28-32. doi: 10.1016/j.jns.2007.10.023. Epub 2007 Nov 19.
6
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.无创通气对肌萎缩侧索硬化症患者生存率和生活质量的影响:一项随机对照试验。
Lancet Neurol. 2006 Feb;5(2):140-7. doi: 10.1016/S1474-4422(05)70326-4.
7
Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole.接受利鲁唑治疗的肌萎缩侧索硬化症患者生存的预后因素。
Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Mar;6(1):37-44. doi: 10.1080/14660820510027035.
8
Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study.在Cox模型对流行病学队列数据的分析中时间尺度的选择:一项模拟研究
Stat Med. 2004 Dec 30;23(24):3803-20. doi: 10.1002/sim.2098.
9
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.多学科肌萎缩侧索硬化症(ALS)诊所对ALS患者生存期的影响:一项基于人群的研究,1996 - 2000年
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1258-61. doi: 10.1136/jnnp.74.9.1258.
10
Age at diagnosis and the choice of survival analysis methods in cancer epidemiology.癌症流行病学中诊断时的年龄与生存分析方法的选择
J Clin Epidemiol. 2003 Jan;56(1):38-43. doi: 10.1016/s0895-4356(02)00536-x.